FDA faces flatlined budget as clock ticks for Congress to pass government funding
The FDA likely won’t receive any more funds through the end of this fiscal year when compared to last year, according to the first of congressional leaders’ much-anticipated appropriations bills packages expected to pass by Friday.
Lawmakers released a six-bill package of appropriations that would allot the FDA about $6.7 billion, including about $3.5 billion in discretionary funding and almost $3.2 billion in user fees, which drug and device developers pay for the agency to review their products.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
